Aeterna Zentaris
AEZS
#10173
Rank
C$23.95 M
Marketcap
C$7.82
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): C-$2.77

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is C-$2.80. In 2022 the company made an earnings per share (EPS) of C-$6.40 a decrease over its 2021 EPS that were of C-$2.49.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$2.77
2022C-$6.40157.14%
2021C-$2.49-41.48%
2020C-$4.25-64.46%
2019C-$11.97-240%
2018C$8.55-122.32%
2017C-$38.30-53.53%
2016C-$82.41-86.71%
2015C-$620.30-35.21%
2014C-$957.46-216.67%
2013C$820.68-123.3%
2012C-$3,522-40.8%
2011C-$5,950-6.45%
2010C-$6,360-27.91%
2009C-$8,822-61.61%
2008C-$22,97983.61%
2007C-$12,515-195.31%
2006C$13,131178.26%
2005C$4,719-330%
2004C-$2,052-80.05%
2003C-$10,28417.78%
2002C-$8,732515.93%
2001C-$1,418-68.6%
2000C-$4,515119.62%
1999C-$2,056-3.63%
1998C-$2,133

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$10.07-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$2.82-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$4.06-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.49-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
C$6.69-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA